SLV330, a cannabinoid CB1 receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats

@article{Bruin2011SLV330AC,
  title={SLV330, a cannabinoid CB1 receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats},
  author={N.M.W.J. de Bruin and Jana Lange and Cornelis Gerrit Kruse and A.H.J. Herremans and A. N. M. Schoffelmeer and Marlies Van Drimmelen and Taco J. de Vries},
  journal={Behavioural Brain Research},
  year={2011},
  volume={217},
  pages={408-415}
}

Figures and Tables from this paper

Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats
TLDR
The results indicate that ACD is able to induce and maintain an operant behavior, a high number of responses during extinction, an increase in the lever presses during the reinstatement phase, and a higher emission of punishments during the conflict experiments, when compared to controls.
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats
TLDR
It is demonstrated that footshock stress increases prefrontal cortical endocannabinoids and stress-potentiated reinstatement is CB1R-dependent, suggesting that CB 1R is a potential therapeutic target for relapse prevention, particularly in individuals whose cocaine use is stress-related.
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
TLDR
The results indicate that AM4113 could be a promising therapeutic option for the prevention of relapse to nicotine-seeking while lacking anxiety/depression-like side effects.
Cannabinoid CB1 Receptor Activation Mediates the Opposing Effects of Amphetamine on Impulsive Action and Impulsive Choice
TLDR
An important, though complex role for cannabinoid CB1 receptor activity in the regulation of impulsive action and impulsive choice is indicated as well as the opposite effects amphetamine has on both forms of impulse behavior.
Mitragynine (Kratom)-Induced Cognitive Impairments in Mice Resemble Δ9-THC and Morphine Effects: Reversal by Cannabinoid CB1 Receptor Antagonism
TLDR
A plausible role of the CB1 receptor in mediating the dose-dependent cognitive deficits after chronic high-dose mitragynine exposure is suggested and the potential of CB1 receptors antagonism in ameliorating the cognitive deficits associated with long-term kratom/mitragynines consumption in humans is highlighted.
Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder
TLDR
The results indicate that both cannabinoid and adenosine receptors modulate impulsive behavior in SHR: the antagonism of cannabinoid receptors might be effective in reducing impulsive symptoms present in ADHD; in addition, caffeine showed the opposite effects on impulsive Behavior depending on the length of treatment.
...
1
2
3
4
...

References

SHOWING 1-10 OF 62 REFERENCES
Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol‐seeking behavior in rats
TLDR
Evidence is provided that blockade of CB1 receptors reduces both ethanol self‐administration and conditioned reinstatement of alcohol‐seeking behavior in rats, suggesting that an altered function of the CB1 receptor system exists between genetically selected alcohol‐preferring msP rats and a heterogeneous animal population.
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
TLDR
Results suggest that activation of the endogenous cannabinoid system may participate in the motivational and dopamine-releasing effects of nicotine and ethanol, and may be effective in reduction of alcohol consumption, as previously suggested, and as an aid for smoking cessation.
Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.
TLDR
Additional data indicate that the opioid receptor antagonists, naloxone and naltrexone, synergistically potentiate the suppressing effect of rimonabant on alcohol intake and alcohol's motivational properties in rats.
Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.
TLDR
Bidirectional changes in ethanol self-administration by the systematically administered CB1 agonist and antagonist show that ethanol reinforcement is controlled by CB1 receptors in alcohol-preferring AA rats.
Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)
TLDR
Results showing the persistence of a nicotine-conditioned behavior are congruent with the role of nicotine-related environmental stimuli in nicotine craving in abstinent smokers and indicate that the cues required learned association with nicotine to acquire reinforcing properties and to function as conditioned reinforcers.
Cannabinoid CB1 receptors control conditioned drug seeking.
...
1
2
3
4
5
...